We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 147 results
  1. Semaglutide

    Agostino Milluzzo, Laura Sciacca in L'Endocrinologo
    Article Open access 08 March 2022
  2. Membrane fusion reverse micelle platforms as potential oral nanocarriers for efficient internalization of free hydrophilic peptides

    Orally administered peptides or proteins are garnering increasing preference owing to their superiority in terms of patient compliance and...

    Mengting Lin, Linjie Wu, ... Min Han in Nano Research
    Article 14 April 2023
  3. Adipositastherapie – werden Pharmakotherapien die Alternative zur metabolischen Chirurgie sein?

    Obesity is a chronically progressing disease that represents a major challenge for affected patients, health care professionals and society, since it...

    Timo D. Müller, Matthias Blüher in Gynäkologische Endokrinologie
    Article 07 September 2023
  4. Therapeutic Peptides and Proteins: Stabilization Challenges and Biomedical Applications by Means of Nanodelivery Systems

    The delivery of peptides and proteins usually faces formulation development challenges attributed to the difficulties encountered in their...

    Elisa Berselli, Carlotta Coccolini, ... Eliana B. Souto in International Journal of Peptide Research and Therapeutics
    Article Open access 28 February 2024
  5. Therapeutic Peptide Delivery: Fundamentals, Formulations, and Recent Advances

    Recent advances in the field of peptide therapeutics have led to the design and synthesis of many promising peptides. However, research and...
    Deepal Vora, Amruta A. Dandekar, Ajay K. Banga in Peptide Therapeutics
    Chapter 2022
  6. Obesity: A Disease of Overnutrition

    Obesity is a serious worldwide problem that is increasing in prevalence. Obesity results from increased energy intake from food exceeding what is...
    George A. Bray, Catherine M. Champagne in Nutritional Health
    Chapter 2023
  7. Effect of Swallow Balloon Therapy with the Combination of Semaglutide Oral Formulation: a Randomised Double-Blind Single-Centre Study

    Background

    Obesity is a significant public health issue; new therapies and pharmaceutical approaches to weight management are needed.

    Objective ...
    Winni Mathur, Susmit Kosta, ... Mohit Bhandari in Obesity Surgery
    Article 13 December 2023
  8. Adipositastherapie – werden Pharmakotherapien die Alternative zur metabolischen Chirurgie sein?

    Obesity is a chronically progressing disease that represents a major challenge for affected patients, health care professionals and society, since it...

    Timo D. Müller, Matthias Blüher in Die Innere Medizin
    Article 07 June 2023
  9. Injektionstherapie (GLP1-Rezeptor Agonisten und Insulin) bei Typ 2 Diabetes mellitus (Update 2023)

    The present article is a recommendation of the Austrian Diabetes Association for the practical use of injection therapy (GLP1-receptor agonists and...

    Monika Lechleitner, Michael Roden, ... T. C. Wascher in Wiener klinische Wochenschrift
    Article Open access 01 January 2023
  10. The evolution of commercial drug delivery technologies

    Drug delivery technologies have enabled the development of many pharmaceutical products that improve patient health by enhancing the delivery of a...

    Ava M. Vargason, Aaron C. Anselmo, Samir Mitragotri in Nature Biomedical Engineering
    Article 01 April 2021
  11. Moderne Therapie bei Typ-2-Diabetes

    Bianca Bach in CME
    Article 20 April 2021
  12. Peptide permeation enhancers for improving oral bioavailability of macromolecules

    Background

    Oral delivery of macromolecules has been limited mainly by their low intestinal permeability. Chemical permeation enhancers (CPEs) are...

    Dohyun Kim, Lan **, ... Dong Hee Na in Journal of Pharmaceutical Investigation
    Article 20 December 2022
  13. Post-Transplant Diabetes Mellitus

    Post-transplant diabetes mellitus (PTDM) is one of the important metabolic complications occurring in about 10–20% of the patients following kidney...
    Manoj Bhattarai, Suverta Bhayana in Complications in Kidney Transplantation
    Chapter 2022
  14. Semaglutide and the risk of diabetic retinopathy—current perspective

    Ashish Sharma, Nikulaa Parachuri, ... Francesco Bandello in Eye
    Article 09 August 2021
  15. The Thyroid Pathologist Meets Therapeutic Pharmacology

    The effects of many pharmacological agents on thyroid function are well known. Direct influences on measurements of thyroid function tests are also...

    Christopher M. Sande, Isabella Tondi Resta, Virginia A. Livolsi in Endocrine Pathology
    Article 01 February 2023
  16. Pediatric Ambulatory Surgery: What’s New, What’s Controversial

    Purpose of Review

    This article aims to review recent innovations and trends in ambulatory anesthesia through the lens of the pediatric ambulatory...

    Audra M. Webber, Marjorie P. Brennan, James Bradley in Current Anesthesiology Reports
    Article 04 March 2024
  17. Challenges and Opportunities in the Delivery of Oral Anticancer Therapeutics

    Global cancer prevalence has continuously increased in the last decades despite substantial progress achieved for patient care. Cancer is no longer...
    Mahfoozur Rahman, Kainat Alam, ... Sarwar Beg in Hormone Related Cancer Mechanistic and Nanomedicines
    Chapter 2022
  18. Identification of a Multi-Component Formulation for Intestinal Delivery of a GLP-1/Glucagon Co-agonist Peptide

    Purpose

    Oral delivery of therapeutic peptides has been challenging due to multiple physiological factors and physicochemical properties of peptides....

    Huyen Tran, Phenil J. Patel, ... Amita Datta –Mannan in Pharmaceutical Research
    Article 01 September 2022
  19. Drug shortages in Israel, revisited: a bitter pill to swallow

    Background

    In 2017, we published an article addressing drug shortages (DS) in Israel, exploring regulatory perspectives, challenges, and potential...

    Eyal Schwartzberg, Eli Marom, ... Segev Shani in Israel Journal of Health Policy Research
    Article Open access 18 March 2024
  20. The effect of semaglutide on blood pressure in patients with type-2 diabetes: a systematic review and meta-analysis

    Objective

    To evaluate the blood pressure (BP) lowering ability of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), in individuals...

    Wei Wu, Huo-mu Tong, ... Jia Cui in Endocrine
    Article Open access 15 December 2023
Did you find what you were looking for? Share feedback.